Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lloyd Clark

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
JAMA Ophthalmology|February 3, 2017
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular EdemaW Lloyd Clark, David S Boyer, Peter K Kaiser
BMC Ophthalmology|January 10, 2019
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusionW Lloyd Clark, Mimi Liu, John Kitchens, et al.
Retina (Philadelphia, Pa.)|September 17, 2024
PROSPECTIVE TRIAL OF HOME OPTICAL COHERENCE TOMOGRAPHY-GUIDED MANAGEMENT OF TREATMENT EXPERIENCED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTSNancy M Holekamp, Anthony M de Beus, W Lloyd Clark, et al.
Retina (Philadelphia, Pa.)|April 21, 2004
Metastatic breast carcinoma to the vitreousRenzo A Zaldivar, Mark Michels, Kenneth F Grant, et al.
Retinal Cases & Brief Reports|December 10, 2015
SEVERE PANUVEITIS, RETINAL VASCULITIS, AND OPTIC DISK GRANULOMA SECONDARY TO SARCOIDOSISMichael Patterson, Chris S Bergstrom, W Lloyd Clark, et al.
American Journal of Ophthalmology|February 17, 2019
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular DegenerationCharles C Wykoff, W Lloyd Clark, Jared S Nielsen, et al.
The British Journal of Ophthalmology|April 19, 2020
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year resultsJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
Ophthalmology|November 13, 2016
Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
The British Journal of Ophthalmology|August 18, 2017
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension studyCharles C Wykoff, William C Ou, Rahul N Khurana, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
JAMA Ophthalmology|February 3, 2017
Controversies in Using Off-Label Intravitreous Bevacizumab for Patients With Diabetic Macular EdemaW Lloyd Clark, David S Boyer, Peter K Kaiser
BMC Ophthalmology|January 10, 2019
Baseline characteristics associated with early visual acuity gains after ranibizumab treatment for retinal vein occlusionW Lloyd Clark, Mimi Liu, John Kitchens, et al.
Retina (Philadelphia, Pa.)|September 17, 2024
PROSPECTIVE TRIAL OF HOME OPTICAL COHERENCE TOMOGRAPHY-GUIDED MANAGEMENT OF TREATMENT EXPERIENCED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTSNancy M Holekamp, Anthony M de Beus, W Lloyd Clark, et al.
Retina (Philadelphia, Pa.)|April 21, 2004
Metastatic breast carcinoma to the vitreousRenzo A Zaldivar, Mark Michels, Kenneth F Grant, et al.
Retinal Cases & Brief Reports|December 10, 2015
SEVERE PANUVEITIS, RETINAL VASCULITIS, AND OPTIC DISK GRANULOMA SECONDARY TO SARCOIDOSISMichael Patterson, Chris S Bergstrom, W Lloyd Clark, et al.
American Journal of Ophthalmology|February 17, 2019
Randomized Trial of Treat and Extend Ranibizumab With and Without Navigated Laser Versus Monthly Dosing for Diabetic Macular Edema: TREX-DME 2-Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
Journal of Managed Care & Specialty Pharmacy|February 1, 2018
Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular DegenerationCharles C Wykoff, W Lloyd Clark, Jared S Nielsen, et al.
The British Journal of Ophthalmology|April 19, 2020
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year resultsJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
Ophthalmology|November 13, 2016
Randomized Trial of Treat and Extend Ranibizumab with and without Navigated Laser for Diabetic Macular Edema: TREX-DME 1 Year OutcomesJohn F Payne, Charles C Wykoff, W Lloyd Clark, et al.
The British Journal of Ophthalmology|August 18, 2017
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension studyCharles C Wykoff, William C Ou, Rahul N Khurana, et al.
Pageof 4